November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Study Highlights Overlooked Role of CMV in Severe Infant HIV Pneumonia

❤️ Conditions & Care 2 min read 👁 11

A new clinical trial challenges current treatment assumptions by pointing to cytomegalovirus as a potentially neglected pathogen in infants living with HIV who suffer from severe pneumonia.

❤️Conditions & Care

Key points

  • EMPIRICAL trial examines overlooked pathogens in infant HIV pneumonia
  • Cytomegalovirus identified as a potential hidden factor in disease severity
  • Standard treatments currently focus on bacteria, Pneumocystis, and tuberculosis

Severe pneumonia among infants living with HIV continues to carry unacceptably high mortality rates despite standard interventions. Current global medical guidelines typically prompt clinicians to act quickly with broad-spectrum antibiotics, supportive care, and empirical treatments for conditions like Pneumocystis jirovecii pneumonia or tuberculosis in regions with high disease burdens.

However, recent findings from the EMPIRICAL trial, led by Cinta Moraleda and her research team, suggest that medical protocols may be missing a critical underlying factor. The study calls attention to cytomegalovirus (CMV), indicating that this pathogen could be playing a significant yet frequently overlooked role in the severity of respiratory infections among this vulnerable patient population.

What to Know About Infant Pneumonia and HIV Protocols

  • Infants with HIV suffering from severe pneumonia face high fatality rates despite standard antibiotic and anti-microbial treatments.
  • The EMPIRICAL trial suggests that cytomegalovirus may be a hidden driver of disease severity that warrants greater clinical attention.
  • Medical experts emphasize that any changes to diagnostic or treatment approaches require consultation with healthcare professionals for personalized medical decisions.

“The EMPIRICAL trial by Cinta Moraleda and colleagues challenges another long-standing assumption; perhaps one important pathogen has been hiding in plain sight.”

While these insights point toward potential gaps in current care strategies, experts note that translating trial results into routine clinical practice requires careful evaluation. Healthcare providers continue to stress that individual treatment plans must be managed closely by qualified medical professionals.

Source The Lancet — thelancet.com/journals/lancet/article/PIIS0140-6736(26)01546-1/full… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.